COMP <GO>
LOAR vs TMO // ENTERPRISE SCALE & MARKET CAP
Loar Holdings Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: LOAR 6
— TMO 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $62.11 (-4.17%) • MKT CAP: $6.07B
market-cap
$6.07B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LOAR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LOAR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.70% | 41.00% | +11.70 | LOAR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.70% | 9.30% | -4.60 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 53.5x | 30.4x | +23.10 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 1.48% | 2.40% | -0.92 | TMO | /fcf-yield <GO> |
| Operating Margin | 21.40% | 17.40% | +4.00 | LOAR | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 15.10% | -15.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 23.20% | 3.90% | +19.30 | LOAR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.85 | 4.50 | +0.35 | LOAR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | LOAR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.8 | 59.1 | -12.33 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.94 | +0.16 | LOAR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 36.3x | +103.70 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $6.07B | $262.22B | -$256.15B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LOAR REV | TMO REV | LOAR GROSS % | TMO GROSS % | LOAR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $496.3M | $44.56B | 52.7% | 44.0% | $89.9M | $6.29B |
| FY 2024 | $402.8M | $42.88B | 49.4% | 44.0% | $36.8M | $7.27B |
| FY 2023 | $317.5M | $42.86B | 44.0% | 44.0% | -$1.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LOAR // BETA 1.10
TMO // BETA 0.94